MP18: Imaging/Uroradiology I
302B
Poster and Podium Sessions
Imaging/Radiology
Information
Continuing Medical Education
CME
Friday, May 3
MP18-01: Increased Provoked Bladder Compliance Associated with High Urgency Bother in a Subset of Women ≥50 Years Old Using Ultrasound Urodynamics
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-02: Does Deep Learning Reconstruction Improve Ureteral Stone Detection and Subjective Image Quality in the CT Images of Patients with Metal Hardware?
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-03: Novel development of the visual uroflowmetry using color laser-light sheets
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-04: Cerebellar structural connectivity relates to lower urinary tract function: a 7T study
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-05: Echogenicity Enhances Risk Assessment of Lesions on MP-MRI for Clinically Significant Prostate Cancer
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-06: Multi-Institutional Development and Validation of a Radiomic Model to Predict Prostate Cancer Recurrence following Radical Prostatectomy
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-07: Multiparametric MRI is more accurate to distinguish T1 versus T2 primary bladder tumours compared to conventional MRI: A Prospective Study.
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-08: The relationship between uptake on PSMA PET imaging and clinical and genomic factors in initial staging for patients with prostate cancer
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-09: More than meets the eye: Evaluating the effect of novel neoadjuvant androgen signaling inhibition on prostate multiparametric MRI
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-10: A PHASE 1, OPEN-LABEL, MULTI-CENTER, NON-RANDOMIZED STUDY OF [F-18]SMS-5368 POSITRON EMISSION TOMOGRPHY IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE AND NEGATIVE CONVENTIONAL IMAGING
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-11: Impact of Prostate MRI Quality (PI-QUAL) on Clinically Significant Prostate Cancer Detection Rates
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-12: Preoperative MRI Anatomical Predictors of Early Continence after Single-Port Transvesical Robot-Assisted Radical Prostatectomy
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-13: Transformer-based large model with mp-MRI for non-invasive auxiliary diagnosis of prostate cancer: a multi-center study
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-14: A multi-institutional prospective study of focal therapy with histotripsy using high-intensity focused ultrasound for patients with localized prostate cancer in Japan
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-15: The Impact of Magnetic Resonance Imaging-detected Zonal Location on Prostate Cancer Recurrence: Implications for Preoperative Risk Stratification
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-16: Biparametric MRI Performance is Comparable to Multiparametric MRI for the Accurate Detection of Clinically Significant Prostate Cancer
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-17: Arginine-rich peptide conjugates enhance tumor-targeted imaging and delivery mediated by the Piezo1/ Integrin β1 axis in bladder cancer
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-18: IMPACT OF 18F-DCFPYL PSMA PET ON ACCURACY of mpMRI IN MEN WITH LOW AND INTERMEDIATE RISK PROSTATE CANCER: INTERIM ANALYSIS OF A PHASE II DIAGNOSTIC TRIAL
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-19: Utility of Low Dose Computed Tomography in Obese Patients with Urolithiasis
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B
MP18-20: Development of a 3D Tumor Model Fusion Pipeline for Renal Mass Ablation: Outcomes and Insights from a High-Volume Center
Friday, May 3, 2024 3:30 PM to 5:30 PM
302B